Home » Blog » $4M Seed Round Focused on Glaucoma Treatment
Avisi Technologies, a 2020 Rosenman Innovator, raised $4.06 million to accelerate clinical development of its VisiPlate product, an ocular implant that treats glaucoma, the world’s leading cause of irreversible blindness.
